Could BIORESTORATIVE THERAPIES INCORPORATED (OTCMKTS:BRTX) Change Direction After Less Shorts?

September 17, 2017 - By Marry Poplack

The stock of BIORESTORATIVE THERAPIES INCORPORATED (OTCMKTS:BRTX) registered a decrease of 12.12% in short interest. BRTX’s total short interest was 2,900 shares in September as published by FINRA. Its down 12.12% from 3,300 shares, reported previously. With 300 shares average volume, it will take short sellers 10 days to cover their BRTX’s short positions.

It closed at $3.19 lastly. It is down 0.00% since September 17, 2016 and is . It has underperformed by 16.70% the S&P500.

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, involving adult stem cells. The company has market cap of $17.77 million. The Firm offers human and plant stem cell derived cosmetic and skin care products. It currently has negative earnings. The Company’s programs relate to the treatment of disc/spine disease and metabolic disorders and include Disc/Spine Program (brtxDISC) and Metabolic Program (ThermoStem).

More notable recent BioRestorative Therapies Inc (OTCMKTS:BRTX) news were published by: Orthospinenews.com which released: “BioRestorative Therapies Announces Completion of Human Safety and Feasibility …” on July 01, 2016, also Globenewswire.com with their article: “BioRestorative Therapies Submits IND Application to FDA to Treat Patients with …” published on January 09, 2017, Globenewswire.com published: “BioRestorative Therapies Receives FDA Clearance to Initiate Phase 2 Clinical …” on February 08, 2017. More interesting news about BioRestorative Therapies Inc (OTCMKTS:BRTX) were released by: Globenewswire.com and their article: “BioRestorative Therapies, Inc. Announces Reverse Stock Split in Preparation …” published on July 06, 2015 as well as Businesswire.com‘s news article titled: “BioRestorative Therapies Appoints Joseph B. Swiader to its Board of Directors” with publication date: July 02, 2014.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.